Bakkt BKKT Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

MarshMRSH

$10M+300%

Comfort Systems USAFIX

$10.37M+176%

Rocket Lab USA, Inc.RKLB

$187K—

Tetra TechTTEK

$58K-97.0%

Tetra TechTTEK

$58K-97.0%

ANI PharmaceuticalsANIP

-$182K+98.5%

Other financials

Income statement

See full

Revenue$577.9M+13.3%

Operating income-$16.9M-9.6%

Net income-$11.7M-251%

EPS (diluted)-$0.41-136%

Balance sheet

See full

Cash & equivalents$80.0M+248%

Total debt$79.0K—

Total equity$170.9M+288%

Total assets$213.4M+21.0%

Cash flow

See full

Operating cash flow-$12.1M+88.1%

CapEx$19.0K-95.9%

Free cash flow-$101.4M-377%

Valuation

See full

Market cap$350.06M+286%

Enterprise value$270.15M—

P/S0.1×-0.2×

Profitability

See full

Operating margin-1.9%-0.8pp

Net margin-0.8%-0.3pp

FCF margin-3.4%—

Returns & leverage

See full

Return on equity-117.8%+1,634pp

Debt / equity0×—

Current ratio4.1×+2.5×

Where this comes from

Reported directly by Bakkt in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Bakkt ’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bakkt 's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bakkt 's contingent consideration fair value adjustments?: Bakkt (BKKT) reported contingent consideration fair value adjustments of $0 in Q4 2025.